CatalystWireBeta

Total Voting Rights

In brief · summary, not quotable

CVS Group plc announced that employees exercised options under the 2023 and 2024 SAYE plans, resulting in the issuance of 390 new ordinary shares, each with a value of 0.2 pence. These shares were satisfied by the company's block listing from December 30, 2021. Following this issuance, the company's total issued share capital is 71,595,964 ordinary shares, each carrying one voting right. The company holds no ordinary shares in treasury, therefore the total number of voting rights is also 71,595,964. This figure can be used by shareholders to calculate their interest in the company under FCA rules.

Full announcement

Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes

CVS, the UK's listed veterinary group and a leading provider of veterinary services, confirms that certain employees have exercised options during September under the CVS Group 2023 SAYE Plan (2023-2026) and 2024 SAYE Plan (2024/2027) totalling 390 ordinary shares of 0.2 pence each ("Ordinary Shares").

The sum of 390 new Ordinary Shares were issued to satisfy the balance of Ordinary Shares arising from the SAYE Exercise. Admission of the 390 new Ordinary Shares has been satisfied by the Company's block listing admitted to the London Stock Exchange on 30 December 2021.

The Company has a total issued share capital of 71,595,964 Ordinary Shares, each carrying one voting right. The Company holds no Ordinary Shares in treasury and the total number of voting rights is therefore 71,595,964.

Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.

Share this quote

Quote card
Post on X WhatsApp Download image

The link opens this announcement with the quote highlighted. Quotes are checked against the original text.

Add a note